These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 35356961)

  • 21. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe.
    Veneman TF; Tack CJ; van Haeften TW
    Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
    Massi-Benedetti M; Herz M; Pfeiffer C
    Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the efficacy and safety profile of sitagliptin versus glimepiride in patients of type 2 diabetes mellitus inadequately controlled with metformin alone.
    Srivastava S; Saxena GN; Keshwani P; Gupta R
    J Assoc Physicians India; 2012 Mar; 60():27-30. PubMed ID: 22799111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of glimepiride and rosiglitazone from Chinese dietary supplements].
    Fujita Y; Honma H; Satoh J; Fujino Y; Onodera M; Inoue Y; Endo S
    Chudoku Kenkyu; 2011 Mar; 24(1):51-6. PubMed ID: 21485125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
    González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
    J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration].
    Fujieda N; Hazekawa I; Araki E
    Nihon Ronen Igakkai Zasshi; 2013; 50(4):550-4. PubMed ID: 24047673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycaemia due to interaction of glimepiride with isoniazid in a patient with type 2 diabetes mellitus.
    Boglou P; Steiropoulos P; Papanas N; Bouros D
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23595176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.
    Sato R; Watanabe H; Genma R; Takeuchi M; Maekawa M; Nakamura H
    Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.
    Leiter LA; Yoon KH; Arias P; Langslet G; Xie J; Balis DA; Millington D; Vercruysse F; Canovatchel W; Meininger G
    Diabetes Care; 2015 Mar; 38(3):355-64. PubMed ID: 25205142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.
    Gudipaty L; Rosenfeld NK; Fuller CS; Gallop R; Schutta MH; Rickels MR
    Diabetes Care; 2014 Sep; 37(9):2451-8. PubMed ID: 24969577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone hydrochloride/glimepiride.
    Blake EW
    Drugs Today (Barc); 2007 Jul; 43(7):487-97. PubMed ID: 17728849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing chemical functionality in Fmoc-peptide gels for cell culture.
    Jayawarna V; Richardson SM; Hirst AR; Hodson NW; Saiani A; Gough JE; Ulijn RV
    Acta Biomater; 2009 Mar; 5(3):934-43. PubMed ID: 19249724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New in-situ gelling biopolymer-based matrix for bioavailability enhancement of glimepiride; in-vitro/in-vivo x-ray imaging and pharmacodynamic evaluations.
    Awadeen RH; Boughdady MF; Meshali MM
    Pharm Dev Technol; 2019 Jun; 24(5):539-549. PubMed ID: 30259768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
    Nissen SE; Nicholls SJ; Wolski K; Nesto R; Kupfer S; Perez A; Jure H; De Larochellière R; Staniloae CS; Mavromatis K; Saw J; Hu B; Lincoff AM; Tuzcu EM;
    JAMA; 2008 Apr; 299(13):1561-73. PubMed ID: 18378631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering.
    Eskandari S; Guerin T; Toth I; Stephenson RJ
    Adv Drug Deliv Rev; 2017 Feb; 110-111():169-187. PubMed ID: 27356149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.